by Eric Christianson | Mar 8, 2026 | Endocrine Medication and Disease State Clinical Pearls
Diabetes management can be quite complex as it is a progressive disease, and goals can change depending on a variety of patient factors. In general, the ADA suggests an A1C goal of <7%, but in some cases, less stringent goals like <8% may be appropriate. The...
by Eric Christianson | Mar 4, 2026 | Neurology, Pain, and Musculoskeletal Case Studies
Medication reviews in patients with rheumatoid arthritis often uncover clinically significant drug therapy problems. Methotrexate toxicity, drug interactions, and therapeutic duplication are common issues that pharmacists must proactively identify. In this case-based...
by Eric Christianson | Mar 1, 2026 | Uncategorized
The last year as a pharmacy student can be a challenge with juggling rotations, projects, job/residency applications, and interviews, just to name a few. The transition from student to licensed pharmacist can be overwhelming, and it is easy to miss a simple step in...
by Eric Christianson | Feb 25, 2026 | Cardiovascular Medication and Disease State Clinical Pearls
When a patient presents with dizziness, falls, or orthostatic symptoms, antihypertensives and diuretics often get the blame first. However, many non–blood pressure medications can lower blood pressure through a variety of mechanisms. Failing to recognize these...
by Eric Christianson | Feb 22, 2026 | Cardiovascular Medication and Disease State Clinical Pearls
Tachycardia is a common and sometimes overlooked adverse effect in clinical practice. Whether it is due to direct sympathetic stimulation, reflex mechanisms, or reflex compensatory mechanisms, understanding the “why” behind medication-induced tachycardia can help...
